1. P441 Long-term immunogenicity of vedolizumab in ulcerative colitis and Crohn's disease (GEMINI Programme). (25th January 2019) Authors: Wyant, T; Yang, L; Lirio, R; Rosario, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP79 Effect of vedolizumab on surgical rates in IBD: post hoc analysis from the GEMINI trials. (25th January 2019) Authors: Feagan, B G; Sands, B E; Lirio, R; Lissoos, T; Wang, J; Feng, D; Lasch, K Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S077 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P632 Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence. (15th January 2020) Authors: Varghese, D; Patel, D; Martin, S; Luo, M; Ursos, L; Lirio, R; Wang, S Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P185 A comparison of early response parameters to inform a treat-to-target approach in ulcerative colitis. (15th January 2020) Authors: Dulai, P; Feagan, B; Sands, B; Lasch, K; Lirio, R; Feng, D Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S231 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P271 Evolving Targets in Ulcerative colitis: Defining Disease Clearance in the VARSITY Study. (27th May 2021) Authors: Danese, S; Schreiber, S; Loftus, E; Colombel, J F; Peyrin-Biroulet, L; Agboton, C; Lindner, D; Lirio, R; Sands, B Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗